Joint Corp. (JYNT)
12.75
0.02 (0.16%)
At close: Mar 24, 2025, 3:59 PM
12.09
-5.15%
After-hours: Mar 24, 2025, 04:54 PM EDT
0.16% (1D)
| Bid | 10.74 |
| Market Cap | 193.44M |
| Revenue (ttm) | 14,465.6B |
| Net Income (ttm) | -8.54M |
| EPS (ttm) | -0.1 |
| PE Ratio (ttm) | -127.47 |
| Forward PE | 27.1 |
| Analyst | Strong Buy |
| Ask | 13.44 |
| Volume | 98,275 |
| Avg. Volume (20D) | 49,936 |
| Open | 12.89 |
| Previous Close | 12.73 |
| Day's Range | 12.54 - 13.37 |
| 52-Week Range | 9.58 - 17.82 |
| Beta | 1.62 |
About JYNT
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona....
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Nov 11, 2014
Employees 443
Stock Exchange NASDAQ
Ticker Symbol JYNT
Website https://www.thejoint.com
Analyst Forecast
According to 2 analyst ratings, the average rating for JYNT stock is "Strong Buy." The 12-month stock price forecast is $17.5, which is an increase of 37.28% from the latest price.
Stock ForecastsNext Earnings Release
Joint Corp. is scheduled to release its earnings on May 1, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+7.21%
The Joint Corp shares are trading higher after the...
Unlock content with
Pro Subscription
10 months ago
+25.35%
Joint shares are trading higher after the company reported better-than-expected Q1 financial results and reiterated FY23 system-wide sales guidance. Also, Roth MKM reiterated a Buy rating on the stock and raised its price target from $13 to $16.
